Cargando…
Personalized chemotherapy selection for breast cancer using gene expression profiles
Choosing the optimal chemotherapy regimen is still an unmet medical need for breast cancer patients. In this study, we reanalyzed data from seven independent data sets with totally 1079 breast cancer patients. The patients were treated with three different types of commonly used neoadjuvant chemothe...
Autores principales: | Yu, Kaixian, Sang, Qing-Xiang Amy, Lung, Pei-Yau, Tan, Winston, Lively, Ty, Sheffield, Cedric, Bou-Dargham, Mayassa J., Liu, Jun S., Zhang, Jinfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335706/ https://www.ncbi.nlm.nih.gov/pubmed/28256629 http://dx.doi.org/10.1038/srep43294 |
Ejemplares similares
-
Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2020) -
Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2018) -
Secretome analysis reveals upregulated granzyme B in human androgen-repressed prostate cancer cells with mesenchymal and invasive phenotype
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2020) -
Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2021) -
TCGA RNA-Seq and Tumor-Infiltrating Lymphocyte Imaging Data Reveal Cold Tumor Signatures of Invasive Ductal Carcinomas and Estrogen Receptor-Positive Human Breast Tumors
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2023)